Stempeutics out licenses its stem cell product to Cipla for treating Diabetic Foot Ulcer EP News Bureau Sep 16, 2019 Under this agreement, Cipla will get the exclusive marketing rights for five years in India for DFU product with Stempeutics…
Stempeutics to launch stem cell device in India by mid 2016 Sanjiv Das Oct 15, 2015 The device will be used for later treatment of osteoarthritis and diabetic foot ulcer to even breast augmentation surgery…
Stempeutics receives ODD in the European Union for Stempeucel Usha Sharma Jun 2, 2015 Stempeucel is used in the treatment of Thromboangiitis Obliterans
Stempeutics receives ATMP classification from EMA for its novel stem cell drug Stempeucel Usha Sharma Mar 23, 2015 The first stem cell drug-based on pooling technology to be granted ATMP classification Stempeutics Research, a group company of…